UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

 


 

FORM 8-K

 

CURRENT REPORT

 

PURSUANT TO SECTION 13 OR 15(d) OF THE

SECURITIES EXCHANGE ACT OF 1934

 


 

Date of Report (Date of earliest event reported):  May 7, 2013

 

BOSTON SCIENTIFIC CORPORATION

(Exact name of registrant as specified in its charter)

 

DELAWARE

 

1-11083

 

04-2695240

(State or other

 

(Commission

 

(IRS employer

jurisdiction of

 

file number)

 

identification no.)

incorporation)

 

 

 

 

 

One Boston Scientific Place, Natick, Massachusetts

 

01760-1537

(Address of principal executive offices)

 

(Zip code)

 

Registrant’s telephone number, including area code:  (508) 650-8000

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o            Written communication pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o            Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o            Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o            Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 



 

ITEM 5.07.                               SUBMISSION OF MATTERS TO A VOTE OF SECURITY HOLDERS.

 

(a)    Boston Scientific Corporation (the “Company”)  held its 2013 Annual Meeting of Stockholders (the “Annual Meeting”) on May 7, 2013 at its Corporate Headquarters located in Natick, Massachusetts.

 

(b)    The final voting results on each of the matters submitted to a vote of stockholders at the Annual Meeting are set forth below.

 

(1)                                 The following nominees were elected to the Company’s Board of Directors for a one-year term to hold office until the Company’s 2014 Annual Meeting of Stockholders and until their successors have been elected and qualified.

 

Nominee

 

For

 

Withheld

 

Broker Non-Votes

 

Katharine T. Bartlett

 

1,040,201,690

 

 20,999,930

 

81,832,017

 

Bruce L. Byrnes

 

1,055,152,709

 

   6,048,911

 

81,832,017

 

Nelda J. Connors

 

1,055,602,385

 

   5,599,235

 

81,832,017

 

Kristina M. Johnson

 

1,042,573,244

 

 18,628,376

 

81,832,017

 

Michael F. Mahoney

 

1,051,227,335

 

   9,974,285

 

81,832,017

 

Ernest Mario

 

   915,528,087

 

145,673,533

 

81,832,017

 

N.J. Nicholas, Jr.

 

1,032,421,589

 

  28,780,031

 

81,832,017

 

Pete M. Nicholas

 

1,007,200,286

 

  54,001,334

 

81,832,017

 

Uwe E. Reinhardt

 

1,052,754,004

 

    8,447,616

 

81,832,017

 

John E. Sununu

 

1,055,279,895

 

    5,921,725

 

81,832,017

 

 

(2)                                 The advisory vote on the compensation for the Company’s “Named Executive Officers” as disclosed in the Company’s proxy statement for the Annual Meeting was approved.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

984,903,344

 

69,825,914

 

6,472,362

 

81,832,017

 

 

(3)                                 The appointment of Ernst & Young LLP as the Company’s independent registered public accounting firm for the 2013 fiscal year was ratified.

 

For

 

Against

 

Abstain

 

Broker Non-Votes

 

1,121,712,675

 

13,594,702

 

7,726,260

 

0

 

 

2



 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

BOSTON SCIENTIFIC CORPORATION

 

 

 

 

Date:  May 9, 2013

By:

/s/ Vance R. Brown

 

 

Vance R. Brown

 

 

Vice President and Chief Corporate Counsel

 

3